key: cord-0036253-s9vehizm authors: Jeanene Bengoa, A.; McCoy, Clyde B.; Foley, Brian T.; Puri, Shikha; Mendez, Alejandro J.; Shapshak, Paul title: Zika Virus and HIV/AIDS date: 2017-09-28 journal: Global Virology II - HIV and NeuroAIDS DOI: 10.1007/978-1-4939-7290-6_30 sha: b2b8275bc20b01a8e09ed20d34946314a2f63e7b doc_id: 36253 cord_uid: s9vehizm The first documented cases of HIV/AIDS in the United States bewildered physicians as they presented an unusual disease spectrum. Two young men were diagnosed with Kaposi sarcoma and Pneumocystis carinii pneumonia, which was inexplicable at that time, as these health outcomes were rare among their age, race/ethnicity, and individuals not living in nursing homes. Subsequently, it was found that after infection with HIV, individuals were asymptomatic up to 4 weeks and if symptoms developed, they appeared as a simple type of flu. The progression and global proliferation of the HIV pandemic is mirrored by the spread of Zika virus (ZikaV). Humans were probably first infected with HIV in the Kinshasa region in the 1940s and ZikaV was first detected in humans in the Zika forest in the 1950s. Aedes aegypti and Aedes albopictus mosquitoes transmit ZikaV, an arbovirus, as well as other related arboviruses. In addition to mosquito transmission, ZikaV transmission occurs through sexual risk and blood transfusions. The latter two risk factors were prominent modes of transmission during the early stages of HIV/AIDS epidemic and sexual transmission risk remains prominent. In addition, injection drug use is a risk factor to become HIV infected. For HIV, blood transfusion risk was reduced after appropriate testing of blood supplies. Unlike HIV, ZikaV does not produce significant symptoms that require medical attention among four-fifths of infected individuals. Indeed, initially considered a relatively benign virus, the unexpected emergence of ZikaV in the Americas since 2015, and continuing as a virulent and pathological virus for children and adults, created a sense of fear and distress. These emotional responses parallel the HIV/AIDS epidemic. Clinicians, epidemiologists, and other scientists are currently increasingly laboring to discern the full spectrum of risk, relative to vector and population behaviors, and as with HIV, to develop vaccines and chemotherapy against ZikaV. NIH and Walter Reed ZikaV vaccines are on the way. Viral infections are a continued and expanding threat to global public health and are under continual epidemiological and medical scrutiny. Viral infections cause approximately 11 million deaths, annually, of which 1 million were due to HIV/AIDS, for example, in 2010 [1] . These fatalities are heightened with the periodic epidemics and pandemics of various strains of influenza, Ebola, continued HIV and HCV spread, TB, and many other viruses. These emerging and periodically re-emerging epidemic diseases pose an ongoing threat to global health security. At the end of 2016, the World Health Organization (WHO) Department of Pandemic and Epidemic Diseases (PED) was monitoring worldwide viral outbreaks of avian influenza, coronaviruses (MERS-CoV, SARS), Ebola, Hendra, influenza (seasonal, pandemic), Nipah, Rift Valley fever, viral hemorrhagic fevers (including Ebola, Marburg, Lassa, Crimean-Congo hemorrhagic fever), yellow fever, and ZikaV [2] . The global spread of ZikaV has evolved into a global pandemic since its original emergence in the Americas, since 2015; ZikaV has evolved into a highly virulent and pathological virus for children and adults, becoming a current unparalleled pandemic. The spread of viral diseases is generally associated with fear that can hinder public health efforts [3] . This fear response has been evident in the public's reaction to the Zika pandemic. This and many other factors closely mirror the setting that has existed with HIV. Human immunodeficiency virus (HIV) can lead to acquired immunodeficiency syndrome (AIDS) if not treated. People are unable to rid themselves of HIV completely, even with treatment, unlike some other viruses. Consequently, once infected with HIV, the infection is for life, as reservoirs of infection remain in various organs [4, 5] . HIV is a retrovirus, lentivirus, which has a lipid bilayer envelope. HIV binds to CD4 T-cell and macrophage receptors and infects these and other cell types. HIV contains an RNA genome that is reverse transcribed into proviral DNA, which is integrated into the host cell's genome [6] . Due to its extreme nucleic acid sequence heterogeneity, HIV consists of several different strains, swarms, clades, and recombinant forms. Individuals may harbor different strains, simultaneously [7] [8] [9] 36] . HIV is classified into two overall groups with numeric designations, HIV-1 and HIV-2. HIV-1 is most common and is found globally. HIV-2 is primarily found in Western Africa [10] . Due to its extreme ability to mutate, HIV can escape from immune surveillance and continue infection and proliferation [11] . Figure 30 .1: A representative phylogenetic tree for HIV By infecting blood cells such as CD4 T cells and macrophages, HIV damages the immune system and increases the likelihood of acquiring opportunistic infections [12, 13] . If left untreated, it can take approximately 5-10 years for AIDS to develop [10, 14] . AIDS is considered when the number of CD4 cells falls below 200 cells per cubic millimeter of blood [15] . Without treatment, once diagnosed with AIDS, people typically survive about 3 more years. Life expectancy falls even further due to opportunistic infection, without treatment [7] . Zikavirus (ZikaV) is a flavivirus, which is in the arbovirus group that includes two additional virus subgroups -alphaviruses and bunyaviruses. ZikaV had been considered, originally a relatively mild or benign virus. However, the other related viruses have been known for several years to be associated with several severe and often fatal diseases, including central nervous system disorders, viral meningitis, encephalitis, and many other serious health outcomes. Arboviruses are often in the forefront of discussions regarding public health and their global prominence is a major public health concern. In addition to ZikaV, these viruses include dengue (DEN), Japanese encephalitis (JE), West Nile virus (WNV), chikungunya fever (CHIK), hemorrhagic fevers such as Crimean-Congo hemorrhagic fever (CCHF), and Kyasanur forest disease virus (KFDV) [16] [17] [18] [19] . However, since 2015, in the Americas, ZikaV evolved into a highly virulent and pathological virus for children, nearly seven decades after its discovery. ZikaV has further evolved into strains that are more virulent and lethal for adults as well [19, 20] . In fact, this process of evolving toward increased pathogenicity (pathogenization) appears to be ongoing. Globally, there is an increased association of Guillain-Barré syndrome (GBS) with ZikaV infection as well [21] [22] [23] . Figure 30 .2: A phylogenetic tree for arboviruses with ZikaV highlighted An individual infected with ZikaV will often manifest only mild symptoms or none. The most common symptoms are fever, rash, joint pain, and conjunctivitis. Occasionally, there can be related muscle pain or headaches. ZikaV manifests itself very much like the common flu, and consequently most people do not seek medical attention when infected. Moreover, like the flu, it can last from several days up to a few weeks. An increased association with Guillain-Barré syndrome, an uncommon disease of the nervous system, has also caused concerns. Death results rarely from ZikaV infection. Be that as it may, at the end of 2016, the most distressing effect of ZikaV infection has been for mothers during pregnancy because ZikaV was associated with a brain birth defect -microcephaly. Additional complications for infants born of ZikaV-infected mothers include defects of the eyes, ears, and growth [16] . HIV can be transmitted through several risk factor routes, which disputes the initial assumption in the 1980s that this epidemic was only experienced in limited demographics and/or risk groups. The following are categorical routes for HIV infection and spread. • High risk sexual contact [24] -Anal sex -Vaginal sex -Oral sex -Multiple sexual partners -Lack of condom use -Deep kissing • Needle/syringe sharing [24] [25] [26] [27] [28] [29] • Injecting drug user (IDU) paraphernalia including cottons, cookers, and wash waters [24, [26] [27] [28] [29] • Transmission via mother/prenatal [24] -Pregnancy -Breast feeding • Medical procedures [24] -Blood transfusion -Organ transplantation • Occupational exposure [24] -Needle/syringe stab • Miscellaneous [24] -Bites -Wound contact Recent reviews summarized the status of clinical syndromes involving ZikaV. Issues discussed include ZikaV associated microcephaly, Guillain-Barré syndrome, potential Dengue virus-ZikaV interactions, and the prospects of a future medical establishment response by developing vaccines and other antiviral agents [19, 30] . The following are several risk factors involving ZikaV. ZikaV is transmitted to people primarily through the bite of an infected Aedes species mosquito. These mosquitoes typically lay eggs in standing water, for example, in tires, buckets, bowls, animal dishes, flowerpots, vases, and leaves that trap water in trees. Further, they become infected when they feed on people already infected with ZikaV and then spread the virus to other people through bites [30] . The ZikaV can be transmitted from the mother to an infant near the time of delivery, if the mother contracted the virus during her pregnancy. No cases of ZikaV have surfaced through mothers' breastfeeding. Thus, mothers are continually encouraged to breastfeed even in areas where this virus is prevalent [30] . A man can spread ZikaV to his sexual partners. It is unknown yet whether women can transmit the virus. Moreover, the virus is present in semen longer than blood, stressing the importance of condom use and other such means that prevent the unnecessary transmittal of the ZikaV [30] . In addition, the issue of viral reservoirs continues as has been found with HIV infection. -Public health services are considering the risk of transmission of ZikaV during blood transfusions. Although no confirmed cases have occurred, reports have indicated potential cases in Brazil and historical records indicated that blood donors have tested positive for the virus after they had given blood [30] . Several news sources have reported that donated blood has tested positive for the presence of ZikaV [31] -ZikaV vaccines are on the way from NIH and Walter Reed [30] . Although many modes of transmission for the HIV/AIDS virus are known, graphically presenting these modes will assist in highlighting current and potential mechanisms that can affect the spread of both the HIV/AIDS and ZikaV. Figure Figure 30.4: HIV pathway [32, 33] 35] Early Phase HIV Viral and host cell membranes fuse and viral particle is uncoated. The viral genome is reverse transcribed and the viral pre-integration complex forms. The pre-integration complex is transported throuh the nuclear pore into the nucleoplasm. The viral reverse transcript is integrated into a host chromosome. Viral RNAs are transcribed from the integrated viral genome and processes to generate viral mRNAs and full-length viral genomic RNAs. The viral RNAs are exported through the nuclear pore into the cytosol. Viral mRNAs are translated and teh resulting viral proteins and post-translationally processed. Core particles containing viral genomic RNA and proteins assemble at the host cell membrane and immature viral particles are released by budding. Released particles mature and become infectious. [32, 33] Newly formed and immature pushes itself out of the host CD4 cell. Infectious HIV particles begin the graual deterioation of the immune system and more specifically, CD4+ T cells by either killing or disabling the cell. The HIV infectious particles begin reducing the CD4+ T cell count from the normal range of 800-1,200/mm3 to under 200/mm3, increasing the susceptibility to develop AIDS. After being exposed to killer T cells (CD+ T Cells), infectious HIV particles mutate to avoid complete elimination from the body. HIV additionally begins binding to the co-receptor CCR5 which increases the rate of disease progression and vulnerability to devleoping AIDS. The death of CD4+ T Cells and/or interference of their function creates severe immunosuppression that increases the potential of HIV evolving to AIDS. Figure 30.6 : Zika virus pathway [36] The HIV/AIDS epidemic forever changed the health landscape of the United States as well as globally. A lack of understanding of epidemiology in general and of this virus-caused disease created a sense of fear and apprehension for the public. The first reported case in 1981 at the University of Miami School of Medicine Grand Rounds involved a young Caucasian man of north European descent diagnosed with Kaposi's sarcoma. The physician reporting this case noted how unusual and unique the symptoms were as Kaposi's sarcoma was unknown in the patient's age group or among those of north European decent. In addition, a second unusual case was also reported. This time, the young man had been diagnosed with Pneumocystis carinii pneumonia (PCP) -a disease that usually occurred among the very old and those living in nursing homes. These cases were puzzling and many questions arose including where the patients lived, traveled, what acute or chronic diseases they had, and with whom they interacted. It was further reported there was little in the patients' background information that indicated any major acute or chronic diseases that would suggest they would be susceptible to these illnesses [37] . Figure 30 .7: Map of HIV spread [2] The public misconceptions and misinterpretations of the HIV/AIDS epidemic did not help the scientific attack on this disease; it resulted in a limited embracing of the scientific approach by communities to solve medical issues. Early on, after this virus was discovered, immunologists speculated that HIV infection could perhaps be managed through a vaccine approach [38] . Because of further molecular research, it was ascertained that HIV underwent a high mutation rate making the development of vaccines highly difficult [24] . This fundamental molecular understanding of the mutation rate, gene structure, and evolution of HIV and the AIDS epidemic at the county, state, and national levels is still at the forefront of current concern as well. Figure 30 .8: Multidisciplinary risk framework The HIV-associated novel agglomeration of signs and symptoms was frequently referred to as (1) Gay-Related Immune Deficiency (GRID) and (2) Gay Disease, which indicated a widespread misunderstanding and misconception of HIV epidemiology. The HIV/AIDS epidemic was thought to be primarily transmitted through Zika virus develops and is reserved within the mosquito species Aedes. stream. The single-stranded positive-sence RNA virus then further inhibits the impact of interferon within the blood leading to many sever symptoms such as hemorrhagic fevers. The Zika virus develops in the nucleoli after it has been transported in via a transient transport and then expelled back into the cytoplasm to mature and proliferate. The proliferation of the mature virus results in symptoms such as headaches, rashes, conjuctivitis and muscle pain. Caucasian and/or homosexual males. Moreover, the lifestyles within the United States during this disease's initial phase were not supportive of practices that could help contravene the emerging epidemic. It was a period of substantially increased urbanization, rapidly increased human trafficking and prostitution, venereal diseases, and drug abuse, including the use of hypodermic needle/syringes [39, 40] . Additionally, the sexual "revolution" that occurred during the 1960s and the gay liberation movement in the 1970s enhanced the severity of this new epidemic [38] . These specific manifestations combined with a dearth of scientific knowledge regarding HIV/AIDS further delayed foundation of the most rapid and preventable approaches against acquiring and transmitting HIV. On April 18, 1947 , the first documented case of the ZikaV emerged in the Zika forest of Uganda [31] . This information only surfaced as the monkey, Rhesus 766 was being observed and studied for research on yellow fever, which is an arbovirus related to the ZikaV [24] . Within a year, the virus was isolated from Aedes [41] . Since its discovery, ZikaV global spread was methodically tracked as follows: 1947 -Zika forest, Uganda, Nigeria, east Africa; 1954 -India; 1978 -Indonesia, Malaysia; 1999 -Ivory Coast; 2001 -Sabah, Malaysia; 2007 -Micronesia, Yap Islands, Easter Islands, Nepal, New World, Argentina, Hawaii, Scandinavia, and Saudi Arabia; 2008 -Southeastern Asia and Australia; 2008 -Senegal, Egypt, Pakistan, North Vietnam, Indonesia, the Philippines, and Borneo/Java, USA; 2012 -Singapore, Australia, Tahiti, and Germany. Tracking ZikaV highlights the ability of an initially, supposedly innocuous virus to spread globally [19, 41, 42] . In 2011, ZikaV was first detected in the United States (Colorado), where it was spread by sexual risk, having been brought to the United States by an infected health care worker, who had been in Indonesia [43] . Later, additional cases of ZikaV infection were reported within the United States and its territories, including Puerto Rico, US Virgin Islands, and American Samoa -274 cases had occurred as of March 2016 [44] . As of November 16, 2016, every state and territory (other than Guam and Alaska) had reported cases of Zika totaling 36,323. Locally acquired cases were restricted to South Florida, Samoa, US Virgin Islands and Puerto Rico. Puerto Rico accounted for 86% of these cases [44, 45] . It is interesting to note that as of February 2016, according to WHO, there was no ZikaV detected yet in Sierra Leone (a medium risk country); however, by September 2016, ZikaV was detected in another medium risk area, Cape Verde islands, off the west African coast. (There are 195 countries in the world [46] .) As of the latest report, March 10, 2017, ZikaV has spread to 184 countries, 13 countries report person-to-person spread, 31 countries report CNS malformations including microcephaly, and 23 countries report GBS -all specifically related to ZikaV infection. The spread of ZikaV, therefore, has rapidly expanded its domain. Thus, local and global public health services, in concert, continue to monitor ZikaV infection [21-23, 47, 48] . Several factors probably contributed to the global expansion of ZikaV (as well as many other viruses), including increased urbanization, economic expansion, swelled human populations and migrations, international travel, wars, and global warming. The rapid expansion of the global landscape as well as major climate changes (global warming) augmented the vector of transmission, the Aedes aegyptus and Aedes albopictus mosquitoes (including in Florida). Moreover, increased temperatures not only increase the transmission vectors but also additional health outcomes that can negatively heighten the effects of ZikaV infection. Moreover, there has not been a corresponding increase in quality and quantity of sanitation and healthcare, November 16, 2016 [17] which further contributes to the problem. Sanitary infrastructure and practices are necessary to address the rapid spread of the epidemic; however, pleas for funding of such efforts are underway [19, 20, 49] . The expansion of the ZikaV pandemic has been disturbingly like the HIV/AIDS epidemic. Initially, the HIV/AIDS epidemic was difficult to diagnose, the modes of transmission were not understood and the risk groups were unknown, thus, in retrospect, making the proliferation of this disease all but certain. The recent emergence of ZikaV mirrors similar delays in public health action and understanding that initially accelerated the spread of HIV/AIDS globally. Without a comprehensive and collaborative approach, ZikaV will have a similar damaging effect, globally, as the HIV/AIDS epidemic has had during the past decades. The ZikaV pandemic reinforced that there is global human domination, urban crowding, expanded international travel, disruption of environmental equilibria, and other human behaviors combined with human-caused perturbations in ecologic balance that have promoted several latent infectious agents to emerge so unexpectedly [19, 44] . It is urgent to approach this epidemic through a multidisciplinary and collaborative approach to minimize the spread of the ZikaV [44] . The implementation of a global framework is needed in which collaborative efforts drive the research and clinical efforts for containing and eliminating this new epidemic and to anticipate other epidemics to come [44, 45] . It should be noted that the current damage caused by the ZikaV pandemic was predicted as likely to occur in a 2015 publication [19] . The reasons provided at that time are as follows: global warming and mosquito spread; war, pestilence, and malnutrition; relatedness of clinical symptomatic and immune relatedness to other diseases and their viruses; the proximity of ZikaV molecular and viral properties to all the other related viruses that are well-known to be pathogenic; viral superinfection issues; and lack of support from global economic and social structures. Further, the impact of the ZikaV on pregnancy and newborn infants is different compared with HIV/AIDS. Both viruses can have deleterious effects on mothers and newborn children and have the potential to produce major health challenges and negative birth outcomes. Unlike HIV/AIDS for which manageable chronic interventions have been developed over the decades for both adults and children growing up HIV positive, ZikaV causes additional outcomes including intrauterine growth constraints, eye defects, congenital brain abnormalities, and microcephaly risks for infants, and GBS risk for adults [50] [51] [52] . The immediacy and relationship between ZikaV and pregnancy highlights the viruses' virulence and capability to cause major health challenges for future generations if it is not immediately controlled (Table 30 .1). Local transmission just beginning in the United States though disease is now worldwide No vaccine but many regimens of medication treatment in use No vaccine or medication currently Originated in Africa, Kinshasa, in the early 1900s, years before adverse health seen because of infection Originated in Africa, Zika Forest in 1950s, years before adverse health seen because of infection During the initial phases of the HIV/AIDS epidemic, an accurate diagnosis could not be made and neither were there clinical and/or therapeutic treatments available that were efficient and effective. It is similarly very difficult to discern a "pure" ZikaV diagnosis as it is closely related to dengue and other arbovirus diseases and many of the clinical tests cannot readily distinguish among the viruses [44] . A modern highly diagnostic technique in widespread use for neuroAIDS is brain imaging. Neuroimaging has also become important in ZikaV infection-related microcephaly, GBS, and acute disseminated encephalomyelitis (ADEM) [53, 54] . From the viewpoint of evolution and at the molecular level, HIV and ZikaV are widely divergent although they entered the human framework near each other in tropical Africa. For example, their mutation rates are divergent. The mutation rate of HIV is 4.1 ± 1.7 × 10 −3 mutations per base in a viral genome of 9749 bp. That means that there are about 39.97 mutations per genome for HIV-1. This is the most rapid mutation rate of any living organism on planet Earth. However, in comparison, the mutation rate of ZikaV, in vivo, is 12-25 bases a year, in a viral genome of 10,272 bp. However, comparisons of HIV-1 and ZikaV mutation rates are made difficult because their mutation rates are not measured or reported under identical laboratory or epidemiological conditions [55, 56] . The risk groups, lifestyles, and poor accessibility to preventive measures and healthcare enhanced the spread of the HIV/AIDS epidemic and this trend appears to be paralleled by ZikaV. The different modes of transmission coupled with the rapid spread of ZikaV stresses the importance of being alert, pre-emptive, and proactive rather than reactive to prevent this virus from continuing its pandemic trajectories and trails. The authors report no conflicts of interest. F2.CM.1995.95CM-MP255.AJ249236 After 2015: infectious diseases in a new era of health and development World Health Organization Zika virus [Internet] World Health Organization The role of fear-related behaviors in the 2013-2016 West Africa Ebola virus disease outbreak About HIV/AIDS [Internet] Centers for Disease Control and Prevention Highlights of the global HIV-1 CSF escape consortium meeting HIV is a retrovirus [Internet] HIV is a retrovirus Origin and evolution of HIV Global protein sequence variation in HIV-1B isolates derived from human blood and brain Global virology II -HIV and NeuroAIDS What is HIV/AIDS? [Internet] Welcome to AIDSgov Chapter 25 in Global virology I -identifying and investigating viral diseases The biology of quiescent CD4 T cells, their role in HIV-1 infection and cocaine drug abuse Role of macrophages in the immunopathogenesis of HIV-1 infection WHO HIV/AIDS Laboratory diagnosis manual Laboratory guidelines for enumerating CD4 T lymphocytes in the context of HIV/AIDS World Health Organization Regional office for Southeast Asia Review Article Emerging and re-emerging arboviral diseases in Southeast Asia Centers for Disease Control and Prevention Flavivirus encephalitis immunopathogenesis of disease and immunomodulation Zika virus In: Chapter 18 in Global virology I -identifying and investigating viral diseases Interspecific competition between two invasive species of container mosquitoes, Aedes aegypti and Aedes albopictus (Diptera: Culicidae), in Brazil WHO Situation Report (2017) Zika virus, microcephaly, Guillain-Barre Syndrome (GBS) Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: systematic review Zika virus, microcephaly, Guillain-Barre Syndrome (GBS) HIV transmission -HIV basics Last accessed 1 The risks of injection practices and compliance to risk reduction protocols in the prevention of HIV-1 among injecting drug users Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness Bleach effectively inactivates HIV-1 at short time intervals Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: preliminary laboratory results Parenteral transmission of HIV among injection drug users: assessing the frequency of multi-person use of needles, syringes, cookers, cotton, and water Zika virus -transmissions and risk HIV-1: fifteen proteins and an RNA Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition The evidence that HIV causes AIDS Zika virus In: Global virology From the many one: a collaborative approach In: Wechsberg WM (ed) Lives lost, careers changed, and survival 30 years on: narratives from HIV pioneers Zika virus: new clinical syndromes and its emergence in the Western Hemisphere Sex, drugs, and the continuing spread of AIDS Institutionalization of drug abuse research in academia-One professor's view History of AIDS: emergence and origin of a modern pandemic Zika virus outside Africa Probable non-vector-borne transmission of Zika virus Zika virus in the United States Zika virus in the Americas -yet another arbovirus threat Arthropodborne viral infections of man in Nigeria Ecology of invasive mosquitoes: effects on resident species and on human health Partnerships, not parachutists, for Zika research Zika virus infection in pregnant women in Rio de Janeiro-preliminary report Zika virus and pregnancy: what obstetric health care providers need to know Brain imaging in people with HIV Neuroimaging findings of Zika virus infection: a review article Extremely high mutation rate of HIV-1 in vivo ZIKA-How fast does this virus mutate?